Marché thérapeutique des verrues – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00024332
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 401
Buy Now

Le marché des traitements contre les verrues était évalué à 1 829,54 millions de dollars américains en 2021, il devrait croître à un TCAC de 3,4 % de 2021 à 2028.



La croissance du marché des traitements contre les verrues est attribuée à la hausse la prévalence des infections à papillomavirus humain et la récurrence des verrues génitales, et le développement de nouveaux produits. Cependant, un scénario de diagnostic médiocre dans les pays à faible revenu limite la croissance du marché. Les verrues sont des excroissances cutanées causées par les papillomavirus humains (HPV). Il existe plus de 60 types de VPH, et plusieurs d'entre eux ont tendance à provoquer des verrues sur la peau. Bien que les traitements topiques puissent probablement résoudre le problème des verrues en quelques semaines avec des effets secondaires minimes, ils peuvent ne pas être efficaces tout le temps. Par conséquent, la cryothérapie avec de l'azote liquide est une option appropriée pour le traitement, où le taux de guérison est de 60 à 90 % et le taux de récurrence inférieur à 10 à 20 %. Aux États-Unis, la demande de procédures de traitement des verrues a diminué en raison du changement d'orientation sur COVID 19. La pandémie a causé des ravages dans les chaînes d'approvisionnement mondiales, les marchés de consommation et les économies dans leur ensemble. En conséquence, les mesures mises en œuvre par les gouvernements du monde entier ont eu un impact négatif sur la croissance du marché de la thérapie contre les verrues.



Régions lucratives pour le marché de la thérapie contre les verrues

Perspectives du marchéRising La prévalence des infections à papillomavirus humain et la récurrence des verrues génitales alimentent la croissance du marché thérapeutique des verruesLes verrues sont causées par diverses souches de papillomavirus humains (HPV), et différentes souches provoquent des verrues dans différentes parties du corps. Les personnes en bonne santé qui entrent en contact avec des verrues peuvent contracter l'infection. Selon les Centers for Disease Control and Prevention (CDC), en 2018, ~ 20% de la population, soit ~ 42,5 millions de personnes, aux États-Unis avaient des infections sexuellement transmissibles (IST). De plus, avant la vaccination contre le VPH, les verrues génitales affectaient environ 340 000 à 360 000 femmes et hommes aux États-Unis chaque année. De plus, le taux de récidive des verrues génitales est élevé. Selon le National Center for Biotechnology Information (NCBI), environ 30 % du nombre total de cas de verrues dans le monde devraient régresser au cours des quatre premiers mois suivant l'infection. De plus, les infections au VPH conduisent au cancer du col de l'utérus, et le cancer du col de l'utérus est le quatrième cancer le plus répandu chez les femmes dans le monde. Selon l'Organisation mondiale de la santé (OMS), environ 570 000 nouveaux cas de cancer du col de l'utérus ont été enregistrés en 2018 avec une prévalence élevée dans les pays à faible revenu. Par conséquent, une augmentation de la prévalence des infections à VPH, entraînant une augmentation des cas de verrues, et le taux de récidive élevé des verrues sont à l'origine de la croissance du marché des verrues thérapeutiques. verrues, verrues génitales, verrues planes et autres. Le segment des verrues vulgaires détient la plus grande part du marché. Cependant, le segment des verrues génitales devrait enregistrer le TCAC le plus élevé au cours de la période 2021-2028. Les verrues génitales font référence aux infections sexuellement transmissibles qui sont généralement causées par le VPH. La prévalence croissante des MST et les efforts croissants de recherche et développement pour développer des options de traitement des verrues génitales propulseraient la croissance du marché de ce segment dans les années à venir.



Marché thérapeutique des verrues, par type - 2021 et 2028

Traitement - Aperçus basés sur le traitement, le marché des traitements contre les verrues est encore segmenté en destruction physique, immunomodulation et destruction chimique. Le marché de la destruction physique est en outre segmenté en cryothérapie, ablation chirurgicale et traitement au laser. L'immunomodulation est sous-segmentée en interférons, rétinoïdes et zinc. Le segment de destruction chimique est en outre divisé en bléomycine, cantharidine, acide salicylique et autres. Le segment de la destruction physique détient la plus grande part du marché thérapeutique des verrues et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision. cliniques et autres. Le segment des hôpitaux détient la plus grande part de marché. Cependant, on estime que le segment des soins à domicile enregistre le TCAC le plus élevé au cours de la période de prévision. La croissance projetée du marché pour ce segment peut être attribuée au nombre croissant d'hôpitaux à travers le monde et au nombre croissant d'interventions chirurgicales. monde, ce qui leur permet également de maintenir leur marque sur le marché mondial.



Marché thérapeutique des verrues - par type




  • Verrues vulgaires

  • Verrues génitales

  • Verrues plates

  • Autres


Marché thérapeutique des verrues - par traitement




  • Destruction physique
      < li>Cryothérapie
    • Ablation chirurgicale

    • Traitement au laser



  • Immunomodulation
    • Interférons

    • Rétinoïdes

    • Zinc



  • Destruction chimique
    • Bléomycine

    • Cantharidine

    • Salicylique Acide

    • Autres




Marché thérapeutique des verrues – par utilisateur final




  • Hôpitaux

  • Soins à domicile

  • Cliniques spécialisées

  • Autres


Marché des traitements contre les verrues - par géographie




  • Amérique du Nord
    • États-Unis

    • Canada

    • Mexique



  • Europe
    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne

    • Reste de l'Europe



  • Asie-Pacifique (APAC)
    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • li>
    • Reste de l'APAC



  • Moyen-Orient et Afrique (MEA)
    • Afrique du Sud

    • Arabie saoudite
    • EAU

    • Reste de la MEA



  • Amérique du Sud et centrale (SCAM)
    • Brésil

    • Argentine

    • Reste de SCAM




Profils des entreprises




  • Bausch Health Companies Inc.
  • Nielsen BioSciences, Inc.

  • Euro Vital Pharma GmbH

  • Cipla Inc.

  • Koninklijke Utermöhlen NV

  • Novan, Inc.

  • Scholl's Wellness Company

  • TEVA PHARMACEUTICAL INDUSTRIES LTD

  • Verrica Pharmaceuticals Inc.

  • GlaxoSmithKline plc.

  • AIM ImmunoTech Inc


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are warts therapeutics?

Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.

What are the driving factors for the Warts Therapeutics market across the globe?

The factors that are driving growth of the market are rising prevalence of human papillomavirus infections and recurrence of genital warts and new product developments.

Who are the developments carrying out by major players in the warts therapeutics market?

Various companies have made organic growth strategies in the warts therapeutics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the warts therapeutics market?

North America dominates the global warts therapeutics market due to factors such as rising prevalence of HPV, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the Warts Therapeutics market?

The physical destruction segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders.

Which region is the fastest growing in the Warts Therapeutics market?

Asia Pacific is expected to be the fastest growing region in the warts therapeutics market. The growth of the market in this region is primarily due to supportive government initiatives and research in the field of HPV infection.

The List of Companies - Warts Therapeutics Market

  1. Bausch Health Companies Inc.            
  2. Nielsen BioSciences, Inc.        
  3. Euro Vital Pharma GmbH        
  4. Cipla Inc.       
  5. Koninklijke Utermöhlen NV      
  6. Novan, Inc.    
  7. Scholl's Wellness Company    
  8. TEVA PHARMACEUTICAL INDUSTRIES LTD               
  9. Verrica Pharmaceuticals Inc.    
  10. GlaxoSmithKline plc.              
  11. AIM ImmunoTech Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports